Apolipoprotein E4 in schizophrenia: A study of one hundred sixteen cases with concomitant neuropathological examination

Biological Psychiatry

Volumn 42, Issue 4, 1997, Pages 296-298

  Powchik, Peter ^a,b   Friedman, Joseph ^a   Haroutunian, Vahram ^a   Greenberg, David ^a   Altsteil, Larry ^a   Purohit, Dushyant ^a   Perl, Daniel ^a   Davidson, Michael ^a  

^a MOUNT SINAI SCHOOL OF MEDICINE   (United States)

^b NONE   (United States)

Author keywords

apolipoprotein E4; dementia; genotype; postmortem analysis; prospective study; schizophrenia

Indexed keywords

APOLIPOPROTEIN E4;

AGED; ALZHEIMER DISEASE; ARTICLE; AUTOPSY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; SCHIZOPHRENIA;

AGED; AGED, 80 AND OVER; ALZHEIMER DISEASE; APOLIPOPROTEIN E4; APOLIPOPROTEINS E; FEMALE; GENOTYPE; HUMANS; MALE; PROSPECTIVE STUDIES; SCHIZOPHRENIA;

EID: 0030797494     PISSN: 00063223     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0006-3223(97)00034-6     Document Type: Article

References (16)

1. Amouyel P, Launay JM, Laplanche JL for the French Research Group on Epidemiology of Human Spongiform Encephalopathies (1994): The apolipoprotein E alleles as major susceptibility factors for Creutzfeld-Jakob disease. Lancet 344: 1315-1317.
2. Arnold SE, Trojanowski JQ (1996): Cognitive impairment in elderly schizophrenia: A dementia (still) lacking distinctive histology. Schizophr Bull 22:5-9.
3. Arnold SE, Franz BR, Trojanowski JQ (1994): Elderly patients with schizophrenia exhibit infrequent neurodegenerative lesions. Neurobiol Aging 15:299-303.
4. Corder EH, Saunders AM, Strittmatter WJ, Schmechel DE, Gaskell PC, Small GW, et al (1993): Gene dose of apolipoprotein E type 4 allele and the risk of Alzheimer's disease in late onset families. Science 261:921-923.
5. Corder EH, Suanders EM, Risch NJ, Strittmatter WJ, Schmechel DE, Gaskell PC, et al (1994): Protective effect of apolipoprotein E type 2 allele for late onset Alzheimer disease. Nat Genet 7:180-184.
6. Davidson M, Harvey PD, Powchik P, Parrella M, White L, Knobler HY, et al (1995): Severity of symptoms in chronically institutionalized geriatric schizophrenic patients. Am J Psychiatry 152:197-207.
7. Helkala EL, Koivisto K, Hanninen T, Vanhanen M, Kervinen K, Kuusisto J, et al (1995): The association of apolipoprotein E polymorphism with memory: A population based study. Neurosci Lett 191:141-144.
8. Henderson AS, Easteal S, Jorm AF, Mackinnon AJ, Korten AE, Christensen H, Croft L, et al (1995): Apolipoprotein allele epsilon4, dementia, and cognitive decline in a population sample. Lancet 346:1387-1390.
9. Hixson JE, Vernier DT (1990): Restriction isotyping of human APOE by gene amplification and cleavage with HhaI. J Lipid Res 31:545-548.
10. Khachaturian ZS (1985): Diagnosis of Alzheimer's disease. Arch Neurol 42:1097-1105.
11. Mirra SS, Heyman A, McKeel D, Sumi SM, Brain BJ, Brownlee LM, et al (1991): The Consortium to Establish a Registry for Alzheimer's Disease (CERAD): Part II. Standardization of the neuropathological assessment of Alzheimer's disease. Neurology 41:479-486.
12. Morris JC, Heyman A, Mohs RC, Hughes JP, van Belle G, Fillenbaum G (1989): The Consortium to Establish a Registry for Alzheimer's Disease (CERAD): Part I. Clinical and neuropsychological assessment of Alzheimer's disease. Neurology 39:1159-1165.
13. Purohit DP, Davidson M, Perl DP, Powchik P, Haroutunian VH, Bierer LM, et al (1993): Severe cognitive impairment in elderly schizophrenic patients: A clinicopathological study. Biol Psychiatry 33:255-260.
14. Rubinstein DC (1995): Apolipoprotein E: A review of its roles in lipoprotein metabolism, neuronal growth and repair and as a risk factor for Alzheimer's disease. Psychol Med 25:223-229.
15. Strittmatter WJ, Saunders AM, Smechel D, Pericak-Vance M, Enghild J, Salvesen GS, et al (1993): Apolipoprotein E: High avidity binding to beta amyloid and increased frequency of type 4 allele in late onset familial Alzheimer disease. Proc Nat Acad Sci, USA 90:1977-1981.
16. Wisniewski T, Frangione B (1992): Apolipoprotein E: A pathological chaperone protein in patients with cerebral and systemic amyloid. Neurosci Lett 135:235-238.